One more step toward treatment of PARP inhibitor-resistant ovarian cancers

Oncotarget. 2023 Dec 22:14:1034-1035. doi: 10.18632/oncotarget.28545.
No abstract available

Keywords: DNA damage; PARP inhibitors; PG545; cell death; ovarian cancer.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents*
  • Female
  • Humans
  • Ovarian Neoplasms* / drug therapy
  • Poly(ADP-ribose) Polymerase Inhibitors / pharmacology
  • Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors
  • Antineoplastic Agents